Delivery Order SPE2DB20D3303-SPE2DB25FZ0P2

Award Date 2/10/25
Potential Completion Date 2/11/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,135.61, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product, with a period of performance ending on February 5, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award, ID SPE2DB20D1004|SPE2DB24FG5P0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4565295207 CLOBAZAM 10 MG TABLET 100S, with a ceiling value of $1,741.38. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of July 31, 2024. The contract does not have a set-aside designation,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,779.65, is for the delivery of 4566422120 CLOBAZAM 10 MG TABLETs. It is a firm fixed-price delivery order contract with a completion date of November 14, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,302.58 firm fixed-price delivery order is for the supply of 4566848238 - CLOBAZAM 10 MG TABLET 100S, with a completion date of January 7, 2025. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) and has a ceiling value of $1,555.93. The contract is a Delivery Order for the procurement of CLOBAZAM 10 MG TABLET 100S, with a completion date of December 10, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and holds a...
This federal contract award, valued at $5,518.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4565154069 - CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FUD22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,866.53 firm-fixed-price delivery order is for the supply of 4566924902 - CLOBAZAM 10 MG TABLET 100S. The contract has an ultimate completion date of January 15, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,143.18 firm fixed-price delivery order is for the supply of 4,566,066,813 units of CLOBAZAM 10 MG TABLET, an anti-seizure medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, Corporate Office Division. The contract has a ceiling value of $3,111.86 and is a Delivery Order for the supply of 4565753155 - CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product. The contract does not have a set-aside designation and has an ultimate completion date of September 11, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,220.14 firm fixed-price delivery order is for the supply of 4567013090 - CLOBAZAM 10 MG TABLET 100S, with a period of performance through January 23, 2025. The award is not associated with any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB25FZ0P2
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,555.93, is a delivery order for the supply of 4567222938 - CLOBAZAM 10 MG TABLET 100S. The contract has a completion date of February 11, 2025 and utilizes a firm fixed-price pricing type. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has been awarded multiple Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs and other federal medical institutions. This contract award does not have a set-aside designation, indicating open competition.

Generated 5/12/25, 10:06 AM